机器人辅助与腹腔镜及开放腹股沟疝修补术后新发持续性阿片类药物使用比较
基于美国商业理赔数据库的回顾性队列研究,纳入2016至2020年接受门诊原发性腹股沟疝修补术的阿片类药物初治患者共41271例。机器人辅助手术与腹腔镜和开放手术相比,长期阿片类药物处方填充风险显著降低,但高剂量阿片类药物填充无差异。
要点
- 机器人辅助腹股沟疝修补术后长期阿片类药物使用风险低于腹腔镜和开放手术。
- 机器人辅助手术与腹腔镜和开放手术相比,高剂量阿片类药物填充风险无显著差异。
- 腹腔镜与开放手术在长期阿片类药物使用方面无显著差异。
核心结论
- 在基于全国商业理赔数据库的队列中,接受机器人辅助腹股沟疝修补术的患者长期阿片类药物使用风险低于腹腔镜和开放手术患者。
研究设计与样本
- 回顾性队列研究,使用Merative MarketScan数据库2016至2020年数据,纳入接受门诊原发性腹股沟疝修补术的阿片类药物初治患者,排除未连续入组、恶性肿瘤、既存慢性疼痛、阿片依赖或处方信息无效者,共41271例(机器人辅助2070例,腹腔镜16704例,开放手术22497例)。
主要发现
- 机器人辅助手术与腹腔镜相比,任何阿片类药物处方填充的OR为0.78(95%CI 0.60至0.98),与开放手术相比OR为0.67(95%CI 0.52至0.85)。
- 机器人辅助手术与腹腔镜相比,II/III类管制阿片类药物处方填充的OR为0.74(95%CI 0.56至0.96),与开放手术相比OR为0.68(95%CI 0.51至0.88)。
- 机器人辅助手术与腹腔镜相比,高剂量阿片类药物填充(>50吗啡毫克当量/天)的OR为0.95(95%CI 0.54至1.55),与开放手术相比OR为0.96(95%CI 0.56至1.52)。
- 腹腔镜与开放手术在长期阿片类药物使用方面无显著差异。
临床怎么用
- 对于接受腹股沟疝修补术的阿片类药物初治患者,机器人辅助手术可能有助于降低长期阿片类药物使用风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Post-operative prescription opioid use is a known risk factor for persistent opioid use. Despite the increased utilization of robotic-assisted surgery (RAS) for inguinal hernia repair (IHR), little is known whether this minimally invasive approach results in less opioid consumption. In this study, we compare long-term opioid use between RAS versus laparoscopic (Lap) versus open surgery for IHR. METHODS: A retrospective cohort study of opioid-naïve patients who underwent outpatient primary IHR was conducted using the Merative™ MarketScan® (Previously IBM MarketScan®) Databases between 2016 and 2020. Patients not continuously enrolled 180 days before/after surgery, who had malignancy, pre-existing chronic pain, opioid dependency, or invalid prescription fill information were excluded. Among patients exposed to opioids peri-operatively, we assessed long-term opioid use as any opioid prescription fill within 90 to 180 days post-surgery. Secondary outcomes were controlled substance schedule II/III opioid fill, and high-dose opioid fill defined as > 50 morphine milligram equivalent per day. An Inverse-probability of treatment weighted logistic regression was used to compare outcomes between groups with p-value of < 0.05 considered statistically significant. RESULTS: A total of 41,271 patients were identified (2070 (5.0%) RAS, 16,704 (40.5%) Lap, and 22,497 (54.5%) open surgery). RAS was associated with less likelihood of prescription fills for any opioid (OR 0.78, 95% CI 0.60 to 0.98 versus Lap; OR 0.67, 95% CI 0.52 to 0.85 versus open), and schedule II/III opioid (OR 0.74, 95% CI 0.56 to 0.96 versus Lap; OR 0.68, 95% CI 0.51 to 0.88 versus open), but comparable high-dose opioid fill (OR 0.95, 95% CI 0.54 to 1.55 versus Lap; OR 0.96, 95% CI 0.56 to 1.52 versus open). Lap and open surgery had no significant difference. CONCLUSION: In this cohort of patients derived from a national commercial claims dataset, patients undergoing RAS had a decreased risk of long-term opioid use compared to laparoscopic and open surgery patients undergoing IHR.
引用
- MacQueen IT, Milky G, Shih IF, et al. New persistent opioid use following robotic-assisted, laparoscopic and open surgery inguinal hernia repair. Surg Endosc. 2024. PMID: 39039294. doi:10.1007/s00464-024-11040-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。